Floatz logo

Benadryl

T-cell Type Acute Leukemia-Precursor

SanofiPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the T-cell Type Acute Leukemia-Precursor cohort.

Asset / SponsorPhaseRating
DEXAMETHASONE
Sanofi
Phase 2B
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 2CCC
Isatuximab
Sanofi
Phase 2CCC
RANITIDINE
Sanofi
Phase 2CCC
Omacetaxine
First Affiliated Hospital of Zhejiang University
Phase 2CCC

View all 19 →

Same molecule, other indications

Benadryl is also rated in:

Relapsing Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Hodgkin LymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →